Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
At close: Feb 6, 2026
Genix Pharmaceuticals Market Cap
Genix Pharmaceuticals has a market cap or net worth of CAD 1.22 million as of February 9, 2026. Its market cap has decreased by -87.84% in one year.
Market Cap
1.22M
Enterprise Value
2.24M
Revenue
68.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since March 27, 1997, Genix Pharmaceuticals's market cap has increased from 33.00 to 1.22M, an increase of 3,710,454.55%. That is a compound annual growth rate of 43.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.22M | -20.00% |
| Dec 23, 2025 | 1.53M | -53.01% |
| Dec 30, 2024 | 3.26M | 175.00% |
| Dec 27, 2023 | 1.18M | -73.33% |
| Dec 19, 2022 | 4.44M | -34.78% |
| Dec 24, 2021 | 6.81M | -32.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmadrug | 2.01M |
| City View Green Holdings | 1.99M |
| Jolt Health | 1.72M |
| Copland Road Capital | 1.44M |
| Ovation Science | 1.34M |
| Adastra Holdings | 1.18M |
| Vencanna Ventures | 1.11M |
| Ayurcann Holdings | 973.52K |